Hepatocyte-specific O-GlcNAc transferase ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function.
Auteur(s) :
Gonzalez-Rellan, M. J. [Auteur]
Universidade de Santiago de Compostela [España] = University of Santiago de Compostela [Spain] = Université de Saint-Jacques-de-Compostelle [Espagne] [USC]
Parracho, T. [Auteur]
Universidade de Santiago de Compostela [España] = University of Santiago de Compostela [Spain] = Université de Saint-Jacques-de-Compostelle [Espagne] [USC]
Heras, V. [Auteur]
Rodriguez, A. [Auteur]
Fondevila, M. F. [Auteur]
Novoa, E. [Auteur]
Lima, N. [Auteur]
Varela-Rey, M. [Auteur]
Senra, A. [Auteur]
Chantada-Vazquez, M. D. [Auteur]
Ameneiro, C. [Auteur]
Bernardo, G. [Auteur]
Fernandez-Ramos, D. [Auteur]
Lopitz-Otsoa, F. [Auteur]
Bilbao, J. [Auteur]
Guallar, D. [Auteur]
Fidalgo, M. [Auteur]
Bravo, S. [Auteur]
Dieguez, C. [Auteur]
Martinez-Chantar, M. L. [Auteur]
Millet, O. [Auteur]
Mato, J. M. [Auteur]
Schwaninger, M. [Auteur]
Prevot, Vincent [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Crespo, J. [Auteur]
Frühbeck, G. [Auteur]
Iruzubieta, P. [Auteur]
Nogueiras, R. [Auteur]
Universidade de Santiago de Compostela [España] = University of Santiago de Compostela [Spain] = Université de Saint-Jacques-de-Compostelle [Espagne] [USC]
Universidade de Santiago de Compostela [España] = University of Santiago de Compostela [Spain] = Université de Saint-Jacques-de-Compostelle [Espagne] [USC]
Parracho, T. [Auteur]
Universidade de Santiago de Compostela [España] = University of Santiago de Compostela [Spain] = Université de Saint-Jacques-de-Compostelle [Espagne] [USC]
Heras, V. [Auteur]
Rodriguez, A. [Auteur]
Fondevila, M. F. [Auteur]
Novoa, E. [Auteur]
Lima, N. [Auteur]
Varela-Rey, M. [Auteur]
Senra, A. [Auteur]
Chantada-Vazquez, M. D. [Auteur]
Ameneiro, C. [Auteur]
Bernardo, G. [Auteur]
Fernandez-Ramos, D. [Auteur]
Lopitz-Otsoa, F. [Auteur]
Bilbao, J. [Auteur]
Guallar, D. [Auteur]
Fidalgo, M. [Auteur]
Bravo, S. [Auteur]
Dieguez, C. [Auteur]
Martinez-Chantar, M. L. [Auteur]
Millet, O. [Auteur]
Mato, J. M. [Auteur]
Schwaninger, M. [Auteur]
Prevot, Vincent [Auteur]

Lille Neurosciences & Cognition (LilNCog) - U 1172
Crespo, J. [Auteur]
Frühbeck, G. [Auteur]
Iruzubieta, P. [Auteur]
Nogueiras, R. [Auteur]
Universidade de Santiago de Compostela [España] = University of Santiago de Compostela [Spain] = Université de Saint-Jacques-de-Compostelle [Espagne] [USC]
Titre de la revue :
Molecular metabolism
Nom court de la revue :
Mol Metab
Numéro :
75
Pagination :
101776
Éditeur :
Elsevier
Date de publication :
2023-07-16
ISSN :
2212-8778
Mot(s)-clé(s) en anglais :
NAFLD
Mitochondrial dysfunction
O-GlcNAcylation
Mitochondrial dysfunction
O-GlcNAcylation
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Objective
O-GlcNAcylation is a post-translational modification that directly couples the processes of nutrient sensing, metabolism, and signal transduction, affecting protein function and localization, since the O-linked ...
Lire la suite >Objective O-GlcNAcylation is a post-translational modification that directly couples the processes of nutrient sensing, metabolism, and signal transduction, affecting protein function and localization, since the O-linked N-acetylglucosamine moiety comes directly from the metabolism of glucose, lipids, and amino acids. The addition and removal of O-GlcNAc of target proteins are mediated by two highly conserved enzymes: O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) and O-GlcNAcase (OGA), respectively. Deregulation of O-GlcNAcylation has been reported to be associated with various human diseases such as cancer, diabetes, and cardiovascular diseases. The contribution of deregulated O-GlcNAcylation to the progression and pathogenesis of NAFLD remains intriguing, and a better understanding of its roles in this pathophysiological context is required to uncover novel avenues for therapeutic intervention. By using a translational approach, our aim is to describe the role of OGT and O-GlcNAcylation in the pathogenesis of NAFLD. Methods We used primary mouse hepatocytes, human hepatic cell lines and in vivo mouse models of steatohepatitis to manipulate O-GlcNAc transferase (OGT). We also studied OGT and O-GlcNAcylation in liver samples from different cohorts of people with NAFLD. Results O-GlcNAcylation was upregulated in the liver of people and animal models with steatohepatitis. Downregulation of OGT in NAFLD-hepatocytes improved diet-induced liver injury in both in vivo and in vitro models. Proteomics studies revealed that mitochondrial proteins were hyper-O-GlcNAcylated in the liver of mice with steatohepatitis. Inhibition of OGT is able to restore mitochondrial oxidation and decrease hepatic lipid content in in vitro and in vivo models of NAFLD. Conclusions These results demonstrate that deregulated hyper-O-GlcNAcylation favors NAFLD progression by reducing mitochondrial oxidation and promoting hepatic lipid accumulation.Lire moins >
Lire la suite >Objective O-GlcNAcylation is a post-translational modification that directly couples the processes of nutrient sensing, metabolism, and signal transduction, affecting protein function and localization, since the O-linked N-acetylglucosamine moiety comes directly from the metabolism of glucose, lipids, and amino acids. The addition and removal of O-GlcNAc of target proteins are mediated by two highly conserved enzymes: O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) and O-GlcNAcase (OGA), respectively. Deregulation of O-GlcNAcylation has been reported to be associated with various human diseases such as cancer, diabetes, and cardiovascular diseases. The contribution of deregulated O-GlcNAcylation to the progression and pathogenesis of NAFLD remains intriguing, and a better understanding of its roles in this pathophysiological context is required to uncover novel avenues for therapeutic intervention. By using a translational approach, our aim is to describe the role of OGT and O-GlcNAcylation in the pathogenesis of NAFLD. Methods We used primary mouse hepatocytes, human hepatic cell lines and in vivo mouse models of steatohepatitis to manipulate O-GlcNAc transferase (OGT). We also studied OGT and O-GlcNAcylation in liver samples from different cohorts of people with NAFLD. Results O-GlcNAcylation was upregulated in the liver of people and animal models with steatohepatitis. Downregulation of OGT in NAFLD-hepatocytes improved diet-induced liver injury in both in vivo and in vitro models. Proteomics studies revealed that mitochondrial proteins were hyper-O-GlcNAcylated in the liver of mice with steatohepatitis. Inhibition of OGT is able to restore mitochondrial oxidation and decrease hepatic lipid content in in vitro and in vivo models of NAFLD. Conclusions These results demonstrate that deregulated hyper-O-GlcNAcylation favors NAFLD progression by reducing mitochondrial oxidation and promoting hepatic lipid accumulation.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Collections :
Date de dépôt :
2024-02-17T22:11:05Z
2024-12-11T09:56:57Z
2024-12-11T09:56:57Z
Fichiers
- 1-s2.0-S2212877823001102-main.pdf
- Version éditeur
- Accès libre
- Accéder au document